GBA1 and Parkinson disease: A recent meta-analysis concluded that GBA1-PD patients carrying pathogenic variants display higher risk of RBD and higher RBD Screening Questionnaire (RBDSQ) scores, whereas LRRK2-PD patients show no difference or reduced risk compared with sPD [15].